JP2015517504A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517504A5 JP2015517504A5 JP2015511877A JP2015511877A JP2015517504A5 JP 2015517504 A5 JP2015517504 A5 JP 2015517504A5 JP 2015511877 A JP2015511877 A JP 2015511877A JP 2015511877 A JP2015511877 A JP 2015511877A JP 2015517504 A5 JP2015517504 A5 JP 2015517504A5
- Authority
- JP
- Japan
- Prior art keywords
- chelate complex
- seq
- pharmaceutical composition
- interferon
- oligonucleotide consisting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261648711P | 2012-05-18 | 2012-05-18 | |
| US61/648,711 | 2012-05-18 | ||
| US201261695035P | 2012-08-30 | 2012-08-30 | |
| US61/695,035 | 2012-08-30 | ||
| PCT/CA2013/050379 WO2013170386A1 (en) | 2012-05-18 | 2013-05-17 | Oligonucleotide chelate complex-polypeptide compositions and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015517504A JP2015517504A (ja) | 2015-06-22 |
| JP2015517504A5 true JP2015517504A5 (cg-RX-API-DMAC7.html) | 2016-07-07 |
Family
ID=49581470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511877A Pending JP2015517504A (ja) | 2012-05-18 | 2013-05-17 | オリゴヌクレオチドキレート錯体−ポリペプチド組成物および方法 |
Country Status (34)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2158316T3 (pl) | 2007-05-11 | 2015-10-30 | Adynxx Inc | Ekspresja genowa oraz ból |
| AU2013259402B2 (en) | 2012-05-10 | 2017-12-21 | Adynxx, Inc. | Formulations for the delivery of active ingredients |
| TWI620568B (zh) | 2012-08-30 | 2018-04-11 | 雷普利可公司 | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 |
| MX381042B (es) | 2014-07-10 | 2025-03-12 | Replicor Inc | Uso de un complejo quelato y un anàlogo de neucleòsido o neucleòtido para tratar infecciones de virus de la hepatitis b y hepatitis d. |
| EP3180434B1 (en) | 2014-08-15 | 2019-07-17 | Adynxx, Inc. | Oligonucleotide decoys for the treatment of pain |
| SG11202104636XA (en) * | 2018-11-08 | 2021-06-29 | Aligos Therapeutics Inc | S-antigen transport inhibiting oligonucleotide polymers and methods |
| US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
| WO2024255846A1 (en) * | 2023-06-16 | 2024-12-19 | Ractigen Therapeutics | Oligonucleotide formulation |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2769114B2 (ja) * | 1993-10-29 | 1998-06-25 | サイクローン・ファーマシューティカルズ | ミニマルｂ型肝炎感染症治療用医薬組成物 |
| UA78726C2 (en) * | 2001-11-01 | 2007-04-25 | Sciclone Pharmaceuticals Inc | Pharmaceutical composition of thymosin alpha 1 conjugated with polyethylene glycol, method for production, and method for treatment |
| BR0314236A (pt) * | 2002-09-13 | 2005-08-09 | Replicor Inc | Formulação de oligonucleotìdeo, composição farmacêutica, kit, composto antiviral, preparação de oligonucleotìdeo e métodos para seleção de um oligonucleotìdeo antiviral para uso como um agente antiviral, para profilaxia ou tratamento de uma infecção viral em um paciente, para tratamento profilático de câncer causado por oncovìrus, para identificação de um composto que altera a ligação de um oligonucleotìdeo a pelo menos um componente viral, para purificação da ligação de oligonucleotìdeos a pelo menos um componente viral e para enriquecimento de oligonucleotìdeos a partir de um agrupamento de oligonucleotìdeos |
| JP2006519235A (ja) | 2003-02-26 | 2006-08-24 | インターミューン インコーポレイティッド | ポリエチレングリコール修飾インターフェロン組成物およびその使用方法 |
| KR20060120162A (ko) * | 2003-10-27 | 2006-11-24 | 버텍스 파마슈티칼스 인코포레이티드 | Ｈｃｖ 치료용 배합물 |
| EP1802643A1 (en) | 2004-10-19 | 2007-07-04 | Replicor Inc. | Antiviral oligonucleotides |
| WO2007022642A2 (en) * | 2005-08-25 | 2007-03-01 | Replicor Inc. | Anti-inflammatory molecules and their uses |
| EP1928498A4 (en) * | 2005-09-29 | 2009-11-11 | Cell Biosciences Inc S | METHOD FOR THE TREATMENT OF T-CELL DISORDERS WITH TISF |
| WO2007036016A1 (en) * | 2005-09-29 | 2007-04-05 | Replicor Inc. | Therapeutic molecules and their uses |
| GB0715383D0 (en) * | 2007-08-08 | 2007-09-19 | Asterion Ltd | Interferon |
| WO2009065181A1 (en) * | 2007-11-21 | 2009-05-28 | Apollo Life Sciences Limited | Nanostructures suitable for delivery of agents |
| AU2008334948B2 (en) | 2007-12-13 | 2014-11-20 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for prevention or treatment of RSV infection |
| US8361980B2 (en) * | 2008-03-07 | 2013-01-29 | Santaris Pharma A/S | Pharmaceutical compositions for treatment of microRNA related diseases |
| CA2764683A1 (en) * | 2009-05-28 | 2010-12-02 | Joseph Collard | Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
| CN102762215A (zh) * | 2009-10-16 | 2012-10-31 | 葛兰素集团有限公司 | Hbv反义抑制剂 |
| SG187165A1 (en) * | 2010-08-20 | 2013-02-28 | Replicor Inc | Oligonucleotide chelate complexes |
| TWI620568B (zh) | 2012-08-30 | 2018-04-11 | 雷普利可公司 | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 |
-
2013
- 2013-05-17 MY MYPI2014003189A patent/MY168778A/en unknown
- 2013-05-17 ES ES13791618T patent/ES2873844T3/es active Active
- 2013-05-17 TW TW102117594A patent/TWI635864B/zh not_active IP Right Cessation
- 2013-05-17 MX MX2014014021A patent/MX346239B/es active IP Right Grant
- 2013-05-17 SG SG11201407599SA patent/SG11201407599SA/en unknown
- 2013-05-17 HR HRP20210840TT patent/HRP20210840T1/hr unknown
- 2013-05-17 EA EA201401278A patent/EA035967B1/ru unknown
- 2013-05-17 KR KR1020147035252A patent/KR102068109B1/ko active Active
- 2013-05-17 SM SM20210319T patent/SMT202100319T1/it unknown
- 2013-05-17 US US13/896,510 patent/US9492506B2/en active Active
- 2013-05-17 WO PCT/CA2013/050379 patent/WO2013170386A1/en not_active Ceased
- 2013-05-17 SI SI201331881T patent/SI2849798T1/sl unknown
- 2013-05-17 BR BR112014028654A patent/BR112014028654A2/pt active Search and Examination
- 2013-05-17 AU AU2013262416A patent/AU2013262416B2/en active Active
- 2013-05-17 CA CA2873529A patent/CA2873529C/en active Active
- 2013-05-17 NZ NZ703095A patent/NZ703095A/en unknown
- 2013-05-17 PT PT137916185T patent/PT2849798T/pt unknown
- 2013-05-17 PL PL13791618T patent/PL2849798T3/pl unknown
- 2013-05-17 EP EP13791618.5A patent/EP2849798B1/en active Active
- 2013-05-17 RS RS20210674A patent/RS62030B1/sr unknown
- 2013-05-17 LT LTEP13791618.5T patent/LT2849798T/lt unknown
- 2013-05-17 CN CN201380026009.3A patent/CN104349793B/zh active Active
- 2013-05-17 HU HUE13791618A patent/HUE054875T2/hu unknown
- 2013-05-17 DK DK13791618.5T patent/DK2849798T3/da active
- 2013-05-17 JP JP2015511877A patent/JP2015517504A/ja active Pending
-
2014
- 2014-11-06 IL IL235548A patent/IL235548B/en active IP Right Grant
- 2014-11-14 PH PH12014502551A patent/PH12014502551B1/en unknown
- 2014-11-18 DO DO2014000264A patent/DOP2014000264A/es unknown
- 2014-11-18 CR CR20140527A patent/CR20140527A/es unknown
- 2014-11-18 CL CL2014003134A patent/CL2014003134A1/es unknown
- 2014-11-18 EC ECIEPI201427694A patent/ECSP14027694A/es unknown
- 2014-11-19 CO CO14254322A patent/CO7131387A2/es unknown
- 2014-11-25 ZA ZA2014/08674A patent/ZA201408674B/en unknown
-
2021
- 2021-05-31 CY CY20211100467T patent/CY1124345T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517504A5 (cg-RX-API-DMAC7.html) | ||
| JP2015528449A5 (cg-RX-API-DMAC7.html) | ||
| JP2010503396A5 (cg-RX-API-DMAC7.html) | ||
| HRP20201953T1 (hr) | Postupci i farmaceutski pripravci za liječenje virusne infekcije hepatitisom b | |
| JP2006516949A5 (cg-RX-API-DMAC7.html) | ||
| US6566344B1 (en) | β-L-2′-deoxy-nucleosides for the treatment of hepatitis B | |
| US9504705B2 (en) | Hepatitis C viral infection treatment using a combination of compounds | |
| TWI620568B (zh) | 用於治療ｂ型肝炎及ｄ型肝炎感染之方法 | |
| JP2013507439A5 (cg-RX-API-DMAC7.html) | ||
| JP2007269798A (ja) | Ｂ型肝炎の治療のためのβ−Ｌ−２’−デオキシ−ヌクレオシド | |
| JP2017521433A5 (cg-RX-API-DMAC7.html) | ||
| JP2015512860A5 (cg-RX-API-DMAC7.html) | ||
| JP2009504157A5 (cg-RX-API-DMAC7.html) | ||
| JP2014513954A5 (cg-RX-API-DMAC7.html) | ||
| JP2013522302A5 (cg-RX-API-DMAC7.html) | ||
| JP2016531144A5 (cg-RX-API-DMAC7.html) | ||
| CA2498731A1 (en) | .beta.-l-2'-deoxynucleosides for the treatment of resistant hbv strains and combination therapies | |
| Brunetto et al. | Interferon therapy of chronic hepatitis B | |
| JP2004533401A5 (cg-RX-API-DMAC7.html) | ||
| HRP20231400T1 (hr) | Kelirani fosforotioirani polimeri nukleinskih kiselina, namijenjeni upotrebi u kombinaciji s inhibitorom hbv polimeraze u liječenju infekcija virusima hepatitisa b i hepatitisa d | |
| TWI635864B (zh) | 寡核苷酸螯合複合物－多肽組合物及方法 | |
| HRP20150430T1 (hr) | Lijeäśenje same virusne infekcije hepatitisa b ili kombinirane s delta virusom hepatitisa te povezanih jetrenih bolesti | |
| JP2010520200A5 (cg-RX-API-DMAC7.html) | ||
| TW202146011A (zh) | 治療b型肝炎病毒感染之組合療法 | |
| CN104968673A (zh) | 融合多肽及使用方法 |